Welcome to our dedicated page for Nugene Intl news (Ticker: NUGN), a resource for investors and traders seeking the latest updates and insights on Nugene Intl stock.
The news page for NUGENE INTERNATIONAL, INC (NUGN) provides an archive of company communications that now identify the issuer as Livento Group, Inc. These press releases describe Livento Group’s activities in acquiring and developing businesses in film and television production, content, technology, robotics, artificial intelligence, and logistics. Readers can review how the company presents its strategy, operational highlights, and corporate developments over time.
Company news frequently focuses on BOXO Productions, the film and television production subsidiary. Releases discuss BOXO’s involvement in specific movies, its ownership stakes in film projects, and initiatives such as the BOXO Fund, which is introduced as an investment product tied to film financing. Updates also highlight milestones around movie releases and performance of titles in which BOXO holds an interest.
Another recurring theme in the news flow is the Robotics and AI division, including the Elisee portfolio management tool and the Novel‑Ti technology business. The company’s releases describe Elisee’s historical performance relative to certain market indices and outline plans for expanding its use. They also discuss the broader Robotics & AI activities and their role in the company’s strategy.
News items additionally cover the company’s relationship with Global Dot Logistics, steps related to OTC market status such as Form 211 submissions and OTCQB applications, and corporate actions including share buybacks and financing agreements. For investors and observers, this page offers a centralized view of how the entity historically known as NuGene International, Inc. and now described as Livento Group, Inc. has communicated its progress, plans, and structural changes.
NuGene International, Inc./Livento Group, Inc. (OTC Pink: NUGN) has initiated the Public Offering process for its logistics project, EuroDot. With final stages underway, legal and financial documents are being prepared for a Reg A listing on OTC Markets. Livento Group aims to attract U.S. investors for future acquisitions, targeting revenues of $50 million by 2024 from two profitable acquisition targets, one with $14 million and another with $20 million in revenues, respectively. Initial share price for investors is set at $0.5. A detailed timeline and further financial disclosures are expected in the coming weeks.
NuGene International, Inc./Livento Group (OTC Pink: NUGN) has signed a binding Letter of Intent to acquire a Software Engineering Company specializing in AI and Robotics. The deal is expected to finalize in January 2023 and aims to enhance Livento's business portfolio. The target company is projected to generate $400,000 in revenue for 2023 with a 50% YOY increase. Additionally, Livento plans to leverage available EU grants of $750,000 to support the acquisition's growth. The acquisition is anticipated to provide positive cash flow from day one.
FAQ
What is the current stock price of Nugene Intl (NUGN)?
What is the market cap of Nugene Intl (NUGN)?
